|
|
|
|
| |
|
| Lacteol Forte: |
|
| |
|
 |
|
|
Unscheduled |
Registration No.: |
Capsules 003621
Sachets 003620 |
|
|
| |
|
An easy-to-use natural
agent:
• No side effects
• No drug interactions
• No risk of overdose
• Simple dosage schedule
A formulation adapted to children:
• Orange-banana flavour
• Taken with a small amount of water
Infants, children, elderly patients
2 sachets immediately and then
1 sachet twice daily
Adults
4 capsules immediately and then
2 capsules twice daily
LACTEOL FORTE
Sachets: 10 Billion heat
killed, freeze-dried Lactobacillus LB* per
sachet
Capsules: 5 Billion heat
killed, freeze-dried Lactobacillus LB* per
capsule
As an adjunct to dietary treatment
* (corresponding to lactobacillus
delbrueckii and lactobacillus fermentum) |
 |
|
|
| |
|
|
Lacteol Forte is unique in that it is
the only lactobacillus, which is heat killed and
freezedried. Lacteol Forte works by exclusion, it
adheres to the brush border cells of the intestinal
mucosa preventing pathogens from attaching, colonizing
and drawing fluid. Lacteol Forte also stimulates the
growth of acidogenic flora and the synthesis of IgA.
|
|
| |
|
|
The advantages of
Lacteol Forte are:
-
Lacteol Forte is
heat killed and freeze dried and therefore does not
need to be kept at 4°C
-
It can be
prescribed for infants and patients with positive
H.I.V. and immunodeficient patients
-
There is no risk
of translocation of infection with Lacteol Forte
unlike pro-biotics
-
There are no side
effects from Lacteol Forte
-
Unlike pro-biotics,
Lacteol Forte can be taken in conjunction with
antibiotics and anti-fungals without being
inactivated
-
Lacteol Forte does
not harbour antibiotic resistance determinants
unlike pro-biotics.
|
|
 |
|
| |
|
* in vitro and in
experimental animals (4)
1 - Chauvière G. et al. Competitive exclusion of
diarrhoeagnic Escherichia coli (ETEC) from human
enterocyte - like Caco-2 cells by heat-killed
Lactobacillus. FEMS Microbiol. Lett., 1992; 91:213-18.
2 - Coconnier M.H. et al. Inhibition of adhesion of
enteroinvasive pathogens to human intestinal Caco-2
cells by Lactobacillus acidophilus strain LB
decreases bacterial invasion. FEMS Microbiol. Lett.,
1993; 110:299-306.
3 - Coconnier M.H. et al. Adhering heat-killed Human
Lactobacillus acidophilus strain LB inhibits the process
of pathogenicity of diarrhoeagenic bacteria
in cultured human intestinal cells. J Diarrhoeal Dis.Res.,
1993; 11(4):235-42.
4 - RCP = Dernière révision : 03/2002.
5 - Dossier d’AMM. Rapport d’expertise.
6 - Fourniat J. et al. Etude de l’activité
bactériosatique du Lactéol Fort gélules sur 101 souches
isolées de selles diarrhéiques. Diagnostics, 1980, 239.
7 - Coconnier M.H. et al. Antibacterial effect of the
adhering human Lactobacillus acidophilus Strain LB.
Antimicrobial Agents and Chemotherapy, May
1997; N0 5, vol 41:1046-52
8 - Cézard J.P. et al. Traitement médicamenteux des
diarrhées aiguës infectieuses du nourrisson et de
l’enfant. Archives de Pédiatrie, 2002; 9:620-28. |
|
| |
|
 |
|
| |
|
|
|
| |
|
